Search results
UC San Francisco Scientists Find Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms...
Sierra Sun Times· 16 hours agoUCSF scientists clear a potential path toward earlier treatment for a disease that affects nearly...
Vertex Pharmaceuticals Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Expansions
GuruFocus.com via Yahoo Finance· 8 hours agoStrategic Acquisition: Announced the acquisition of Alpine Immune Sciences, enhancing the pipeline...
Molly Murray: Why don't we know more about autoimmune diseases? (Opinion)
The Charleston Gazette· 6 days agoImagine feeling unwell for months, years — even decades — and never knowing why. Imagine the anguish of not understanding the suffering taking place in your body and the frustration of it not ...
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343（Anti-Claudin18.2 ADC）as...
WJTV Jackson· 5 hours agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment& ...
Dermatomyositis vs. Polymyositis
Healthline· 6 days agoLearn the similarities and differences between dermatomyositis and polymyositis, two autoimmune conditions.
Meet 2024 Rising Star of the West Finalist Amelie Wilcox
Black Hills FOX· 2 hours agoAmelie Wilcox will achieve a rare feat this week - she’ll graduate from college before graduating...
7 Benefits of Metformin (Including Weight Loss)
MediaFeed via AOL· 3 days agoMetformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for diabetes, you probably already...
Tolerizing vaccines for autoimmune diseases tempt BMS into $1.8bn collaboration
BioPharma-Reporter· 7 days agoBristol Myers Squibb (BMS) has bet up to $1.8bn in a collaboration with Repertoire Immune Medicines...
Insider Sale at Xencor Inc (XNCR): EVP, Chief Development Officer Nancy Valente Sells Shares
GuruFocus.com via Yahoo Finance· 3 days agoThe transaction was documented in a recent SEC Filing. Xencor Inc is a biopharmaceutical company...
TIME100 Health: Georg Schett
Time Magazine· 5 days agoIn recent years, the new immune-based therapy CAR T has dramatically improved outcomes for patients with certain blood cancers that involve B cells, like...
